Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CST1 Predictive Model for Oral Glucocorticoids in CRSwNP
NCT05598424Phase 4Unknown
- Sponsor
- Beijing Tongren Hospital
- Start
- Nov 2022
- Primary completion
- Dec 2024
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of methylprednisolone in chronic rhinosinusitis with nasal polyps (CRSwNP), sponsored by Beijing Tongren Hospital. Primary endpoint: The change in endoscopic polyp score at week 6. Status: unknown.
02
Drugs
methylprednisolone
03
Conditions
chronic rhinosinusitis with nasal polyps (CRSwNP)
Beyond the preview
Go deeper on NCT05598424.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05598424.